ConCallIQ
Go Pro
FLUOROCHEM Diversified 12 Feb 2026

Gujarat Fluorochemicals Limited — Q3 FY26

Gujarat Fluorochemicals reported a challenging Q3 FY26 with revenue of ₹1,136 crore (down 1% YoY) and EBITDA of ₹283 crore (down 7% YoY), impacted by seasonal weakness in refrigerants, US tariff uncertainty, and delayed R32 production.

bearish high
Compare with...
Revenue ₹1,136 Cr -1%
EBITDA ₹283 Cr -7%
PAT ₹102 Cr
EBITDA Margin 24.9% -160bps
Duration 65 min
Read Time 1 min read

✓ Verified against BSE filing

2-Minute Summary

✦ AI-Generated from Full Transcript

Gujarat Fluorochemicals reported a challenging Q3 FY26 with revenue of ₹1,136 crore (down 1% YoY) and EBITDA of ₹283 crore (down 7% YoY), impacted by seasonal weakness in refrigerants, US tariff uncertainty, and delayed R32 production. The refrigerant segment faced a dual blow from R22 quota cuts and weak R125 prices, while fluoropolymers grew 14% YoY but missed the 20% target due to anti-dumping duty rejection and tariff-related deferrals. Battery materials business gained traction with IFC and sovereign fund investments, and commercial supplies of LiPF6 commenced in December 2025. Management expects recovery from tariff reduction (50% to 18%) and R32 ramp-up, but near-term headwinds persist. Key risk: continued weakness in refrigerant pricing and delayed R32 scale-up could pressure margins further.

Promises0 met · 2 missedRisks4 trackedTranscriptfull text
Research workspace

Focused Modules

Promises 2 promises

Promise Tracker

0 delivered, 0 close, 2 missed.

View Promises →
!Risks 4 risks

Risk Intelligence

R22 price weakness and quota constraints

View Risks →
Transcript Full text

Call Transcript

Full transcript text is available on this route.

Read Transcript →

Quarter Snapshot

Fluoropolymer segment revenue growth 14%
+14% YoY

Fluoropolymer segment grew 14% year-on-year, driven by semicon demand, but missed the 20% target due to tariff uncertainty.

R32 capacity target (Phase 1) 20,000 tons
Delayed by ~1 quarter

R32 production started but ramp-up to 20,000 tons delayed to Q1 FY27 vs earlier March 2026 target.

Inventory days 201 days
+81 days vs target

Inventory days rose to 201 from target of 120, due to tariff-related stock buildup and slow offtake.

Battery materials investment (IFC + sovereign fund) ₹430 crore + $82M
New investments

IFC approved ₹430 crore and a sovereign fund approved $82M for battery materials subsidiary, signaling strong investor confidence.

What Changed vs Last Quarter

Comparing Q3 FY26 vs Q2 FY26
4 new guidance4 dropped3 new risk3 risk resolved
NEW
R32 capacity to reach 20,000 tons by Q1 FY27

Phase 1 R32 capacity of 20,000 tons will be commissioned early in calendar year 2026, delayed from March 2026 due to safety audits.

NEW
Battery materials capacities fully utilized by end of FY27

Current LiPF6, LFP CAM, and binder capacities expected to be fully utilized by end of FY27, with revenue ramp-up starting in FY27.

NEW
Working capital days target of 170-180

Management targets reducing inventory days from current 201 to 170-180 in the coming year.

NEW
Oman battery materials plant commissioning in 18 months

Greenfield project in Oman with $216M investment expected to be commissioned in 18 months (mid to end CY27).

DROPPED
R32 capacity target of 20,000 MT by March 2026

Management reaffirmed the target to achieve 20,000 MT R32 capacity by end of FY26, with plant restart expected by end of November 2025.

DROPPED
Battery materials revenue to start in Q4 FY26

Revenue from EV materials business is expected to begin flowing from Q4 of the current financial year.

DROPPED
Battery materials EBITDA breakeven in FY27

Management expects the battery chemicals business to reach EBITDA breakeven in FY27.

DROPPED
Capex of ~₹1,500 crore for battery materials in FY27

Capex for battery materials is expected to be around ₹1,500 crore in FY27, part of the ₹6,000 crore 4-5 year plan.

NEW RISK
R22 price weakness and quota constraints

R22 prices continue to decline, and production quota reductions are limiting volumes, impacting refrigerant segment profitability.

NEW RISK
Delayed R32 ramp-up and missed revenue

R32 production startup delayed by a quarter, pushing expected revenue contribution to Q4 FY26, which may pressure near-term earnings.

NEW RISK
Anti-dumping duty rejection hurting fluoropolymer growth

Finance ministry did not accept DGTR's anti-dumping duty recommendation, impacting domestic fluoropolymer volumes and growth trajectory.

RISK GONE
US tariff uncertainty impacting fluoropolymer exports

Higher US tariffs have caused customers to delay buying decisions, impacting fluoropolymer sales. Management is exploring alternative markets but tariff persistence could weigh on growth.

RISK GONE
R32 plant incident may delay ramp-up

A fire incident at the R32 plant has temporarily halted production. While management expects restart by end of November, any further delays could impact the 20,000 MT target.

RISK GONE
Working capital days elevated due to inventory build

Working capital days have increased to ~182 from 120 in FY22, partly due to inventory for export depots and EV samples. Management expects improvement only after full-scale operations.

🤫 Topics management stopped discussing

Battery materials revenue to trickle in from H2 FY26, meaningful in FY27

Mentioned in Q1 FY26, Q2 FY26

Revenue from EV materials business is expected to begin flowing from Q4 of the current financial year.

Fast read

Guidance and risk preview

Top guidance R32 capacity to reach 20,000 tons by Q1 FY27

Phase 1 R32 capacity of 20,000 tons will be commissioned early in calendar year 2026, delayed from March 2026 due to safety audits.

Top risk R22 price weakness and quota constraints

R22 prices continue to decline, and production quota reductions are limiting volumes, impacting refrigerant segment profitability.

View Risks →